Investrend Announces Investment Opinion: Analyst Piyali Chakravarty Questions if MDI Entertainment Shareholders are Receiving Full Value in Proposed Scientific Games Acquisition.Business Editors NOTE TO EDITORS: The following is an investment opinion issued by Investrend Research NEW YORK--(BUSINESS WIRE)--Feb. 27, 2002 Investrend Research analyst Piyali Chakravarty is questioning whether MDI (1) (Multiple Document Interface) A Windows function that allows an application to display and lets the user work with more than one document at the same time. Entertainment (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :LTRY) shareholders are receiving full value in the company's proposed all-stock acquisition by Scientific Games (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : SGMS SGMS SonicWALL Global Management System ) pegged at $2.10 per share. Chakravarty notes that the market seemed to be validating her 12-month target of $5 by bidding up the company's shares to $3.65, 231% above her report price ($1.10) only last week, and was at $3.25 when the acquisition was announced. She also points out that at the time the proposed merger was announced, Chakravarty was preparing a research update stating that the company's FY01 fully diluted EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. of $0.28 beat her expectations by 8-cents; and that 4Q01 fully diluted EPS numbers at $0.14 beat her estimates of $0.05 by 9-cents. Coincidentally, both Scientific Games and MDI Entertainment have current coverage by Investrend analysts. Scientific Games recently surpassed Investrend analyst Gerald LaKarnafeaux's 12mo target of $8.50. Chakravarty is the MDI Entertainment analyst only. The full ResearchNote is posted at http://www.investrend.com, and Chakravarty's comments may be heard on AnalystBroadcast.Network at http://viavid.com/vvasx/0000046F00000000.asx. To receive research alerts about either company, write info@investrend.com and put "LTRY" or "SGMS" in the subject line. Piyali Chakravarty is a member of AIMR AIMR See Association for Investment Management and Research (AIMR). and the New York Society of Security Analysts. She has experience in equity research and corporate credit analysis and has served institutional and retail clients. Most recently she was a Securities Analyst with Argus Research in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Prior to that, she was an equity analyst for Lazard Brothers and a corporate credit analyst for Credit Lyonnais Bank. She has also worked at T&L Investments as a currency investment consultant. She is a Level 2 candidate in the Chartered Financial Analyst Chartered Financial Analyst (CFA) An experienced financial analyst who has passed examinations in economics, financial accounting, portfolio management, security analysis, and standards of conduct given by the Institute of Chartered Financial Analysts. Program. Ms. Chakravarty received an MBA with Honors from Point Park College in Pittsburgh and an Advanced Professional Certificate in Accounting from Pace University in New York. Investrend Research has been a leading independent fee-based institutional publishing and distribution program since 1996, with more than 45 AIMR-qualified professional analysts posting over 360 reports. Anyone, including a company, investor relations practitioner, financial institution or interested private investor, may enroll a company for analyst coverage. Enrollment fees vary for a number of Investrend Research products, up to $1,850 per month for the premium continuous coverage program. Please read the disclaimers and coverage guidelines at http://www.investrend.com before investing. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion